EMBECTA CORP (EMBC)
NASDAQ • Healthcare
Last close at August 10, 2026 at 20:00 UTC
Fundamentals Charts
About EMBECTA CORP
Embecta Corp. is a healthcare company focused on diabetes care, making injection products and related tools for people living with the disease. Listed on the NASDAQ as EMBC, Embecta sells pen needles, syringes, safety devices, and digital applications, and it generated $1.1 billion of revenue in FY2025.
Analyst Ratings
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings Calendar
Technical Indicators
EMBECTA CORP's Technical Indicators Summary
EMBC shows a short-term bullish posture driven by strong momentum and positive moving-average alignment, while longer-term averages remain overhead. The ADX indicates a moderately firm directional bias, and momentum measures such as MACD and CCI are supportive despite an overbought RSI, suggesting recent upside has been intense. Price sits above the short- and medium-term averages and above the classic pivot, and OBV is positive which lends volume confirmation, while ATR points to moderate intraday volatility. Technical takeaway: Buy.
| Indicator | Value |
|---|---|
RSI (14) | 77.41 |
Stochastic %K (14, 3, 3) | 74.85 |
CCI (20) | 288.53 |
WPR (14) | -1.10 |
Momentum (10) | 1.55 |
MFI | 72.87 |
MACD Level (12, 26) | 0.22 |
Bollinger Bands | $2.69 - $4.46 |
ATR (14) | $0.29 (5.82%) |
ADX (14) | 27.38 |
OBV | -11,851,570 |
Classic Pivot Point | $4.36 |
Fibonacci Pivot Point | $4.36 |
Exponential Moving Averages | $3.71 - $8.15(5 indicators) |
Simple Moving Averages | $3.38 - $8.53(5 indicators) |
Get premium market insights delivered directly to your inbox.
Today's Snapshot
The last trading day produced a massive upside shock for EMBC, which vaulted 12.90%. EMBC faces an August 17, 2026 class-action deadline.
Trading Volume
Above 10d avg 1.9M
3.8M
vs S&P 500 Today
Strong Outperformance
+12.96%
52-Week Position
Lower range
17.4%
Updated: August 11, 2026 at 12:45 UTC